CNO Financial Group Inc
- Market cap
- 4.90B
- P/E (TTM)i
- 18.27
- P/Bi
- 1.89
- EPSi
- 2.30
- Div yieldi
- 1.30%
- 52W posi
- 78%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Fair Value how this is computed
- Implied fair-value range of 3.44-68.41, from this stock's own trailing 5-year average P/E applied to trailing EPS.
- Current price is +47.5% above the average-multiple fair value of 35.92.
Valuation each multiple against its own 5-year range
Vs. peers Insurance - Life
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| CNO Financial Group Inc (CNO) | 4.90B | 18.27 | 1.89 | 1.30% |
| Manulife Financial (MFC) | 68.93B | 16.10 | 2.11 | 3.13% |
| MetLife (MET) | 60.87B | 18.35 | 2.22 | 2.40% |
| Aflac Inc (AFL) | 56.52B | 12.16 | 1.86 | 2.11% |
| Prudential Financial (PRU) | 38.76B | 10.19 | 1.23 | 4.89% |
| Prudential (PUK) | 29.39B | 8.28 | 1.48 | 2.26% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 2.9% below Morningstar's fair value estimate.
Fair value
CNO Financial Group Inc earns a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a price consistent with our quantitative fair value estimate, which has a high uncertainty rating.
The company's valuation metrics increase our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its enterprise value to market value ratio of 1.7, which lies in the top 20% compared with peers globally. While highly leveraged firms can be risky, they can also be highly rewarding. This company's high enterprise value relative to its market value suggests that wise investments will yield outsize returns for investors. This benefit contributes to our balanced fair value estimate.
The firm's balance sheet is an additional encouraging factor. Leverage can enable a company to invest in growth, potentially boosting shareholder value more than equity financing alone. The firm's EBITDA/interest coverage ratio of 4.2, for example, ranks in the bottom 30% compared with peers globally. Although the firm's ability to cover interest payments with EBITDA is limited, shares could sharply rebound if economic circumstances change or recent investments reduce fears of default. This characteristic further promotes our neutral price/fair value ratio.
In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is fairly-valued, this outperformance had a negative impact on our valuation estimate.
Economic moat
The company's quantitative economic moat rating of none suggests any excess returns could erode quickly as competition arrives. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
By Quantitative Equity Report
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.